Skip to content
Catalyst

PapersPMID:40485009

Treatment of Hypovitaminosis D With Cholecalciferol in Dogs With Protein-Losing Enteropathies: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.

Journal of veterinary internal medicine2025The record ↗

  1. Finding, very limited evidenceraisesSerum 25-hydroxyvitamin D concentration

What moved

1 findingHow to read these marks →
  • “Dogs with PLE treated with cholecalciferol had higher 25OHD concentrations at T2 compared to dogs treated with placebo (225 nmol/L, range 72-434 vs. 80 nmol/L, range 31-254 nmol/L; p = 0.004).”
    Study
    animal · not in humans
    Duration
    4 weeks
    Dose studied
    400 IU/kg cholecalciferol PO daily for 6 weeks
    Population
    dogs with protein-losing enteropathy and decreased serum 25OHD, receiving standard PLE therapy in both arms

Study record

Design
randomised controlled trial
Species
animal
Population
28 dogs with protein-losing enteropathy and decreased serum 25OHD
Participants
28
Comparator
not stated in the paper / placebo
Duration
42 days
Endpoints measured
3